aTyr Pharma, Inc. (ATYR) earnings
ATYR earnings moved a median of +5.02% by the close. Quarterly and annual ATYR reports and results, each read against the price at its own news timestamp. Back to the ATYR overview →
16 measured ATYR earnings events.
Where these ATYR earnings landedvs 14 measured ATYR earnings reactions
| Middle 50% of ATYR earnings reactions | +1.15% to +8.81% |
|---|---|
| Median reaction (to close) | +5.02% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 ATYR earnings events with a measured close landed between +1.15% and +8.81%; 86% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q aTYR PHARMA INC For: Sep 30 | SEC filing · Form 10-Q | +5.79% | +11.40% | |
| aTyr Pharma Announces Third Quarter 2026 Results and Provides Corporate Update | Press release | +5.79% | +11.40% | |
| aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD | Press release | +0.31% | — | |
| Form 10-Q aTYR PHARMA INC For: Jun 30 | SEC filing · Form 10-Q | +0.31% | — | |
| aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update | Press release | -9.02% | -13.10% | |
| Form 10-Q aTYR PHARMA INC For: Mar 31 | SEC filing · Form 10-Q | -1.40% | +2.65% | |
| Form 10-K aTYR PHARMA INC For: Dec 31 | SEC filing · Form 10-K | -0.65% | -5.79% | |
| aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update | Press release | +2.03% | +8.92% | |
| Form 10-Q aTYR PHARMA INC For: Sep 30 | SEC filing · Form 10-Q | +2.03% | +8.92% | |
| aTyr Pharma Announces Second Quarter 2025 Results and Provides Corporate Update | Press release | +0.58% | +1.15% | |
| Form 10-Q aTYR PHARMA INC For: Jun 30 | SEC filing · Form 10-Q | +0.58% | +1.15% | |
| aTyr Pharma Announces First Quarter 2025 Results and Provides Corporate Update | Press release | +4.50% | +7.39% | |
| Form 10-Q aTYR PHARMA INC For: Mar 31 | SEC filing · Form 10-Q | +4.50% | +7.39% | |
| Form 10-K aTYR PHARMA INC For: Dec 31 | SEC filing · Form 10-K | +11.18% | +8.47% | |
| aTyr Pharma Announces Third Quarter 2024 Results and Provides Corporate Update | Press release | -2.38% | +2.29% | |
| aTyr Pharma Announces Second Quarter 2024 Results and Provides Corporate Update | Press release | -1.08% | +0.54% |
Keep exploring
More ATYR: analyst actions → · SEC filings → · ATYR overview →